BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7343757)

  • 1. Effect of haloperidol administration on serum MHPG-SO4 levels in chronic schizophrenics.
    Hoaki Y; Nishikawa T; Ida Y; Kohno Y; Tanaka M
    Kurume Med J; 1981; 28(3):197-200. PubMed ID: 7343757
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma free and conjugated MHPG in psychiatric patients. A pilot study.
    Sweeney DR; Leckman JF; Maas JW; Hattox S; Heninger GR
    Arch Gen Psychiatry; 1980 Oct; 37(10):1100-3. PubMed ID: 7425795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
    Chang WH; Chen TY; Lin SK; Lung FW; Lin WL; Hu WH; Yeh EK
    Biol Psychiatry; 1990 Mar; 27(5):510-8. PubMed ID: 2310806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.
    Ko GN; Jimerson DC; Wyatt RJ; Bigelow LB
    Arch Gen Psychiatry; 1988 Sep; 45(9):842-6. PubMed ID: 3415425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).
    Maas JW; Hattox SE; Landis DH; Roth RH
    Brain Res; 1976 Dec; 118(1):167-73. PubMed ID: 825199
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of renal failure on plasma dihydroxyphenylglycol, 3-methoxy-4-hydroxyphenylglycol, and vanillymandelic acid.
    Hoeldtke RD; Israel BC; Cavanaugh ST; Krishna GG
    Clin Chim Acta; 1989 Sep; 184(2):195-6. PubMed ID: 2605785
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of acute and chronic treatment with tricyclic antidepressants on 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SO4) contents in various regions of rat brain.
    Miyauchi T; Kitada Y; Satoh S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(2):137-42. PubMed ID: 7202235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal development of noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulphate levels in rat brain regions.
    Kohno Y; Tanaka M; Nakagawa R; Ida Y; Iimori K; Nagasaki N
    J Neurochem; 1982 Sep; 39(3):878-81. PubMed ID: 7097293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.
    Nutt DJ; Molyneux SG
    Psychopharmacology (Berl); 1986; 90(4):509-12. PubMed ID: 3027736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hypothalamic noradrenergic neuronal activity and serum 3-methoxy-4-hydroxyphenylethylene glycol in the rat.
    Grunstein HS; Gleeson RM; Smythe GA
    Life Sci; 1986 Jul; 39(3):207-13. PubMed ID: 3736321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent phase advance in diurnal MHPG rhythm in depression.
    Gwirtsman HE; Halaris AE; Wolf AW; DeMet E; Piletz JE; Marler M
    Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
    Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
    Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
    Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and CSF MHPG in normals [proceedings].
    Jimerson DC; Ballenger JC; Lake CR; Post RM; Goodwin FK; Kopin IJ
    Psychopharmacol Bull; 1981 Jan; 17(1):86-7. PubMed ID: 7232666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regional characteristics of noradrenaline turnover as reflected in the brain levels of MHPG-SO4].
    Kohno Y
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):175-92. PubMed ID: 6345303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MHPG in depression: effects of acute and chronic desipramine treatment.
    Charney DS; Heninger GR; Sternberg DE; Roth RH
    Psychiatry Res; 1981 Oct; 5(2):217-29. PubMed ID: 6945615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma MHPG in untreated panic disorder.
    Edlund MJ; Swann AC; Davis CM
    Biol Psychiatry; 1987 Dec; 22(12):1491-5. PubMed ID: 3676379
    [No Abstract]   [Full Text] [Related]  

  • 19. Rat brain and plasma norepinephrine glycol metabolites determined by gas chromatography-mass fragmentography.
    Warsh JJ; Godse DD; Cheung SW; Li PP
    J Neurochem; 1981 Mar; 36(3):893-901. PubMed ID: 7205279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
    Miller AL; Maas JW; Contreras S; Seleshi E; True JE; Bowden C; Castiglioni J
    Biol Psychiatry; 1993 Aug; 34(3):178-87. PubMed ID: 8104509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.